Advertisement

Chemotherapy of Disseminated Testicular Cancer

  • Lawrence H. Einhorn
Part of the Developments in Oncology book series (DION, volume 23)

Abstract

Testicular cancer is a relatively rare disease, accounting for only one percent of all male malignancy. Despite the relative paucity of new cases, testis cancer is an extremely important disease.

Keywords

Testicular Cancer Salvage Therapy Testis Cancer Disease Free Status Remission Induction Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Mackay EN, Sellers AH: A statistical review of malignant testicular tumors based on the experience of the Ontario Cancer Foundation Clinics, 1938–1961. Can Med Assoc J 94: 889–899, 1966.PubMedGoogle Scholar
  2. 2.
    Einhorn LH, Williams SD, Mandelbaum I, and Donohue J: Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction. Cancer 48: 904–908, 1981.PubMedCrossRefGoogle Scholar
  3. 3.
    Williams SD, Einhorn LH, Greco FA, Oldham R, and Fletcher R: VP-16-213 salvage therapy for refractory germinal neoplasms. Cancer 46: 2154–2158, 1980.PubMedCrossRefGoogle Scholar
  4. 4.
    Schabel FM Jr, Trader NW, Laster WR Jr: Cis-dichlorodiammineplatinum (II): Combination chemotherapy and cross-resistance studies with tumors of mice. Cancer Treat Rep 63: 1549–1473, 1979.Google Scholar

Copyright information

© Martinus Nijhoff Publishing, Boston 1984

Authors and Affiliations

  • Lawrence H. Einhorn

There are no affiliations available

Personalised recommendations